Dose Finding Study to Treat High Phosphate Levels in the Blood.
Public ClinicalTrials.gov record NCT02081534. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of AZD1722 to Treat Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Randomized. double blind, placebo controlled, parallel arms dose finding study with a 4 weeks treatment period
Study identification
- NCT ID
- NCT02081534
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 162 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2014 (Type not available)
- Primary completion
- Nov 2014 (Actual)
- Completion
- Nov 2014 (Actual)
- Last update posted
- Sep 14, 2020
2014
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Downey | California | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | Sacramento | California | — | — |
| Research Site | Whittier | California | — | — |
| Research Site | Denver | Colorado | — | — |
| Research Site | Pembroke Pines | Florida | — | — |
| Research Site | Tampa | Florida | — | — |
| Research Site | Winter Park | Florida | — | — |
| Research Site | Springfield | Massachusetts | — | — |
| Research Site | Detroit | Michigan | — | — |
| Research Site | Voorhees Township | New Jersey | — | — |
| Research Site | Flushing | New York | — | — |
| Research Site | Maspeth | New York | — | — |
| Research Site | Charlotte | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02081534, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2020 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02081534 live on ClinicalTrials.gov.